UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 177 filers reported holding UNIQURE NV in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $677,146 | -69.6% | 100,916 | -48.1% | 0.00% | -100.0% |
| Q2 2023 | $2,229,910 | -76.8% | 194,582 | -59.2% | 0.00% | -75.0% |
| Q1 2023 | $9,609,217 | -16.6% | 477,121 | -6.1% | 0.00% | -20.0% |
| Q4 2022 | $11,517,698 | +88.2% | 508,059 | +55.7% | 0.01% | +66.7% |
| Q3 2022 | $6,121,000 | -35.0% | 326,268 | -35.4% | 0.00% | -25.0% |
| Q2 2022 | $9,416,000 | +59.2% | 505,156 | +54.3% | 0.00% | +100.0% |
| Q1 2022 | $5,916,000 | +107.6% | 327,411 | +138.2% | 0.00% | +100.0% |
| Q4 2021 | $2,850,000 | +14.2% | 137,431 | +76.3% | 0.00% | 0.0% |
| Q3 2021 | $2,495,000 | +153.8% | 77,959 | +144.2% | 0.00% | – |
| Q2 2021 | $983,000 | -9.1% | 31,923 | +6.7% | 0.00% | -100.0% |
| Q4 2020 | $1,081,000 | – | 29,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 955,424 | $32,188,000 | 5.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 282,034 | $9,490,000 | 2.51% |
| Nantahala Capital Management | 1,672,891 | $56,360,000 | 1.65% |
| Henry James International Management Inc. | 149,053 | $5,022,000 | 1.51% |
| Nantahala Capital Management | 1,500,000 | $50,535,000 | 1.48% |
| Voss Capital, LLC | 90,000 | $3,032,000 | 1.26% |
| P.A.W. CAPITAL CORP | 30,000 | $1,011,000 | 0.89% |
| Sofinnova Investments, Inc. | 427,122 | $14,390,000 | 0.86% |
| Caption Management, LLC | 1,078,800 | $36,343,000 | 0.78% |
| Sivik Global Healthcare LLC | 61,768 | $2,081,000 | 0.76% |